Literature DB >> 2945671

Atrial natriuretic peptide decreases circulatory capacitance in areflexic rats.

N C Trippodo, F E Cole, E D Frohlich, A A MacPhee.   

Abstract

The short-term hemodynamic response to atrial natriuretic peptide appears to be partly mediated by decreased venous return, which could result from increased circulatory capacitance or decreased blood volume. To determine if rat atrial natriuretic peptide 99-126 (0.5 microgram/kg/min IV for 30-70 minutes) dilated capacitance vessels or decreased blood volume, mean circulatory filling pressure (measured during brief circulatory arrest by inflating an intraatrial balloon) and blood volume (51Cr-erythrocytes) were measured in anesthetized rats. Mean circulatory filling pressure, central venous pressure, and blood volume decreased by 0.4 mm Hg, 0.5 mm Hg, and 3.4 ml/kg, respectively. To determine the total circulatory pressure-volume relationship without influence from autonomic reflexes, mean circulatory filling pressure and blood volume were measured in spinal-cord-transected rats before and immediately after infusing or withdrawing 5 ml blood. Atrial natriuretic peptide decreased mean circulatory filling pressure, central venous pressure, and blood volume by 0.9 mm Hg, 1.7 mm Hg, and 8.0 ml/kg, respectively, and displaced the pressure-volume relationship toward the pressure axis by decreasing extrapolated unstressed volume. Similar results were obtained in spinal-cord-transected rats that had initial vascular tone restored to a greater level by norepinephrine infusion. In anephric rats, atrial natriuretic peptide decreased central venous pressure by 0.3 mm Hg and blood volume by 1.6 ml/kg. The results indicate that short-term infusion of atrial natriuretic peptide reduced circulatory capacitance in rats and suggest that this reduction resulted from diminished blood volume due to urinary fluid loss followed by passive vascular recoil and active venoconstriction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945671     DOI: 10.1161/01.res.59.3.291

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

2.  Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure.

Authors:  H Drexler; M Finkh; S Höing; M Toth; H Just; R E Lang
Journal:  Basic Res Cardiol       Date:  1987 Nov-Dec       Impact factor: 17.165

3.  Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

Authors:  H Jin; R H Yang; Y F Chen; R M Jackson; S Oparil
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Different effects of alpha-human atrial natriuretic peptide and nitroglycerin on cardiac dimensions in humans.

Authors:  T Imaizumi; A Takeshita; M Yoshida; S Suzuki; S Ando; Y Hirooka; M Nakamura
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

5.  Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats.

Authors:  X W Qu; R A Rozenfeld; W Huang; S E Crawford; F Gonzalez-Crussi; W Hsueh
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

Review 6.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

7.  The maintenance and monitoring of perioperative blood volume.

Authors:  Takehiko Iijima; Birgitte Brandstrup; Peter Rodhe; Audrius Andrijauskas; Christer H Svensen
Journal:  Perioper Med (Lond)       Date:  2013-05-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.